Yap Te-Lu, Chen Yong, Nah Shireen A, Ong Caroline Choo Phaik, Jacobsen Anette, Low Yee
Department of Paediatric Surgery, KK Women's & Children's Hospital, 100 Bukit Timah Road, Singapore.
Department of Paediatric Surgery, KK Women's & Children's Hospital, 100 Bukit Timah Road, Singapore.
J Pediatr Surg. 2016 Dec;51(12):2015-2020. doi: 10.1016/j.jpedsurg.2016.09.028. Epub 2016 Sep 16.
Our study aimed to compare the efficacy of two endoscopic techniques used for the correction of vesicoureteral reflux (VUR): subureteral transurethral injection (STING) and hydrodistension implantation technique (HIT).
A systematic review was conducted using MEDLINE, Google scholar, and Cochrane databases from 1984 to 2015. Meta-analysis of the selected studies was performed to compare the extent of reflux resolution following both techniques.
Six observational studies met the inclusion criteria for content. These comprised 632 ureters treated by STING and 895 ureters treated by HIT procedure. All included studies utilized dextranomer/hyaluronic acid (Deflux) as the bulking agent. The overall resolution of VUR was significantly higher in HIT (82.5%) compared to STING (71.4%) [pooled odds ratio (OR)=0.54; 95% confidence interval (CI) 0.42-0.69; P<0.0001; I=8%]. A subgroup analysis showed that HIT had better outcomes than STING for both lower grade (I-III) [OR=0.43; 95% CI 0.23-0.82; P=0.01; I=0%] and high-grade VUR (IV-V) [OR=0.43; 95% CI 0.20-0.91; P=0.03; I=0%]. However, there was no statistical difference in the requirement of additional injections between STING and HIT groups.
HIT is superior to STING technique for resolution of VUR after Deflux injection. However, more randomized trials with longer follow-up are necessary to demonstrate the benefit of HIT compared to STING procedure.
Retrospective comparative studies - level III.
我们的研究旨在比较两种用于纠正膀胱输尿管反流(VUR)的内镜技术的疗效:输尿管下经尿道注射(STING)和水扩张植入技术(HIT)。
使用MEDLINE、谷歌学术和Cochrane数据库对1984年至2015年的文献进行系统综述。对所选研究进行荟萃分析,以比较两种技术后反流消退的程度。
六项观察性研究符合内容纳入标准。这些研究包括632条接受STING治疗的输尿管和895条接受HIT治疗的输尿管。所有纳入研究均使用葡聚糖omer/透明质酸(Deflux)作为填充剂。与STING(71.4%)相比,HIT治疗VUR的总体消退率显著更高(82.5%)[合并比值比(OR)=0.54;95%置信区间(CI)0.42-0.69;P<0.0001;I=8%]。亚组分析显示,对于低级别(I-III)[OR=0.43;95%CI 0.23-0.82;P=0.01;I=0%]和高级别VUR(IV-V)[OR=0.43;95%CI 0.20-0.91;P=0.03;I=0%],HIT的效果均优于STING。然而,STING组和HIT组之间额外注射的需求没有统计学差异。
在注射Deflux后,HIT在解决VUR方面优于STING技术。然而,需要更多随访时间更长的随机试验来证明与STING手术相比,HIT的益处。
回顾性比较研究 - III级。